Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter-Directed Thrombolysis Versus ANticoagulation Monotherapy in Patients With Acute Intermediate-High Risk PulmonarY Embolism: The CANARY Randomized Clinical Trial

NCT05172115 is registered in ClinicalTrials.gov with Rajaie Cardiovascular Medical and Research Center as lead sponsor.

NCT NCT05172115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05172115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter-Directed Thrombolysis Versus ANticoagulation Monotherapy in Patients With Acute Intermediate-High Risk PulmonarY Embolism: The CANARY Randomized Clinical Trial
Lead sponsor
Rajaie Cardiovascular Medical and Research Center
Phase
Phase 3
Overall status
Terminated
Start date
December 22, 2018
Completion date
May 2, 2020
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embolism, pulmonary, pulmonary embolism, pulmonary thromboembolisms, right ventricular dysfunction